LENTI.RIGHT

Serial Number 79381397
Registration 7665523
700

Registration Progress

Application Filed
Sep 4, 2023
Under Examination
Approved for Publication
Dec 10, 2024
Published for Opposition
Dec 10, 2024
Registered
Jan 28, 2025

Trademark Image

LENTI.RIGHT

Basic Information

Serial Number
79381397
Registration Number
7665523
Filing Date
September 4, 2023
Registration Date
January 28, 2025
Published for Opposition
December 10, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 28, 2025
Registration
Registered
Classes
005 040 042

Rights Holder

ProBioGen AG

25
Address
Goethestraße 50 - 54
13086 Berlin
DE

Ownership History

ProBioGen AG

Original Applicant
25
DE

ProBioGen AG

Owner at Publication
25
DE

ProBioGen AG

Original Registrant
25
DE

Legal Representation

Attorney
Maryann E. Licciardi

USPTO Deadlines

Next Deadline
2025 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-28)
Due Date
January 28, 2031
Grace Period Ends
July 28, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description
Jan 28, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 28, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2024 PUBO A PUBLISHED FOR OPPOSITION
Dec 4, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 14, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 17, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 17, 2024 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 17, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 17, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 17, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 11, 2024 RFNT P REFUSAL PROCESSED BY IB
Jul 22, 2024 RFRR P REFUSAL PROCESSED BY MPU
Jul 22, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 27, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 26, 2024 CNRT R NON-FINAL ACTION WRITTEN
Apr 30, 2024 DOCK D ASSIGNED TO EXAMINER
Oct 24, 2023 MAFR O APPLICATION FILING RECEIPT MAILED
Oct 20, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 19, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
BIOLOGICAL PREPARATIONS FOR THE TREATMENT OF CANCER AND HEREDITARY DISEASES; DIAGNOSTIC REAGENTS FOR CLINICAL MEDICAL OR CLINICAL LABORATORY USE
Class 040
CONTRACT MANUFACTURING OF PHARMACEUTICALS IN THE FIELD OF BIOCHEMICALS AND VIRAL VECTORS
Class 042
Development of new technology for others in the field of drug discovery and validation, gene expression and delivery, genomics research

Classification

International Classes
005 040 042

USPTO Documents

Loading USPTO documents...